mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.003 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.004 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.005 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.005 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |